Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Wegovy is the only form of semaglutide currently approved for weight loss
15,20 Although many of these AEs have occurred early in therapy and subsided over time, they remain a primary reason for dose adjustment or discontinuation
This is particularly beneficial for menopausal women, as clinical trial data from early 2026 shows that tirzepatide can result in approximately 23% total body weight loss in perimenopausal and postmenopausal populations
Medication such as tirzepatide can offer better weight loss outcomes, whereas orlistat or Qsymia would be cheaper options
Some patients find it helpful to overlap briefly, keeping a small supply of their current medication on hand in case the new product is delayed in shipping
US$ 23.53
US$ 27.21
US$ 20.67
US$ 25.94
US$ 24.20
